The estimated Net Worth of Daniel Skovronsky is at least $113 millió dollars as of 1 February 2024. Daniel Skovronsky owns over 9,941 units of Lilly(Eli) & Co stock worth over $106,143,623 and over the last 6 years he sold LLY stock worth over $0. In addition, he makes $6,662,970 as Senior Vice President, Chief Scientific Officer and President és Lilly Research Laboratories at Lilly(Eli) & Co.
Daniel has made over 5 trades of the Lilly(Eli) & Co stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 9,941 units of LLY stock worth $9,154,567 on 1 February 2024.
The largest trade he's ever made was exercising 18,735 units of Lilly(Eli) & Co stock on 1 February 2022 worth over $17,252,874. On average, Daniel trades about 3,124 units every 108 days since 2018. As of 1 February 2024 he still owns at least 115,262 units of Lilly(Eli) & Co stock.
You can see the complete history of Daniel Skovronsky stock trades at the bottom of the page.
Dr. Daniel M. Skovronsky M.D. Ph.D. serves as Senior Vice President, Chief Scientific Officer and President, Lilly Research Laboratories of the Company. Prior to joining the company in 2010, Dr. Skovronsky was CEO and founder of Avid Radiopharmaceutical Inc.
As the Senior Vice President, Chief Scientific Officer and President és Lilly Research Laboratories of Lilly(Eli) & Co, the total compensation of Daniel Skovronsky at Lilly(Eli) & Co is $6,662,970. There are 2 executives at Lilly(Eli) & Co getting paid more, with David Ricks having the highest compensation of $21,283,200.
Daniel Skovronsky is 47, he's been the Senior Vice President, Chief Scientific Officer and President és Lilly Research Laboratories of Lilly(Eli) & Co since 2018. There are 30 older and 1 younger executives at Lilly(Eli) & Co. The oldest executive at Lilly(Eli) & Co is Kathi Seifert, 71, who is the Independent Director.
Daniel's mailing address filed with the SEC is Eli Lilly and Company Corporate Center, Indianapolis, Marion County, Indiana, United States.
Over the last 20 years, insiders at Lilly(Eli) & Co have traded over $29,994,829,903 worth of Lilly(Eli) & Co stock and bought 73,808 units worth $5,778,435 . The most active insiders traders include Endowment Inc Lilly, R David Hoover és Lorenzo Tallarigo. On average, Lilly(Eli) & Co executives and independent directors trade stock every 7 days with the average trade being worth of $55,447,708. The most recent stock trade was executed by Endowment Inc Lilly on 3 September 2024, trading 24,084 units of LLY stock currently worth $23,281,762.
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.
Lilly(Eli) & Co executives and other stock owners filed with the SEC include: